Europe digital respiratory solutions market reached $2.75 million in 2019 and will grow by 35.9% annually over 2020-2026 owing to the rising demand for respiratory aids and air purification amid COVID-19 pandemic.
Highlighted with 34 tables and 43 figures, this 106-page report “Europe Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe digital respiratory solutions market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe digital respiratory solutions market in every aspect of the classification from perspectives of Product Type, Indication, Distribution Channel, and Country.
Based on Product Type, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Therapeutic Devices
• Inhalers
• Nebulizers
Diagnostic Devices
• Spirometers
• Asthma Monitors
• Other Diagnostic Devices
Sensors and Apps
Based on Indication, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• COVID-19 Caused Diseases
• Other Diseases
Based on Distribution Channel, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe (further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
For each aforementioned country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Product Type, Indication, and Distribution Channel over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Europe digital respiratory solutions market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
3M Health Care Limited
Adherium Limited
Amiko Digital Health Limited
AsthmaMD
AstraZeneca plc
Boehringer Ingelheim International GmbH
Capsule Technologies, Inc.
Cohero Health
GlaxoSmithKline plc
Kaia Health Software GmbH
Medical International Research (MIR)
Novartis AG
NuvoAir
Reciprocal Labs (Propeller Health)
Sensiron AG
Tactio Health
Teva Pharmaceuticals Industries Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 6
1.1 Industry Definition and Research Scope 6
1.1.1 Industry Definition 6
1.1.2 Research Scope 7
1.2 Research Methodology 10
1.2.1 Overview of Market Research Methodology 10
1.2.2 Market Assumption 11
1.2.3 Secondary Data 11
1.2.4 Primary Data 11
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 18
2.1 Market Size and Forecast 18
2.1.1 Impact of COVID-19 on the Market 19
2.2 Major Growth Drivers 21
2.3 Market Restraints and Challenges 26
2.4 Emerging Opportunities and Market Trends 29
2.5 Porter’s Fiver Forces Analysis 33
3 Segmentation of Europe Market by Product Type 38
3.1 Market Overview by Product Type 38
3.2 Therapeutic Devices 40
3.2.1 Inhalers 41
3.2.2 Nebulizers 42
3.3 Diagnostic Devices 43
3.3.1 Spirometers 45
3.3.2 Asthma Monitors 46
3.3.3 Other Diagnostic Devices 47
3.4 Sensors and Apps 48
4 Segmentation of Europe Market by Indication 49
4.1 Market Overview by Indication 49
4.2 Asthma 51
4.3 Chronic Obstructive Pulmonary Disease (COPD) 52
4.4 COVID-19 Caused Diseases 53
4.5 Other Diseases 54
5 Segmentation of Europe Market by Distribution Channel 55
5.1 Market Overview by Distribution Channel 55
5.2 Hospital Pharmacies 57
5.3 Retail Pharmacies 58
5.4 Online Pharmacies 59
6 European Market 2019-2030 by Country 60
6.1 Overview of European Market 60
6.2 Germany 63
6.3 UK 65
6.4 France 68
6.5 Spain 70
6.6 Italy 72
6.7 Russia 74
6.8 Rest of European Market 76
7 Competitive Landscape 78
7.1 Overview of Key Vendors 78
7.2 New Product Launch, Partnership, Investment, and M&A 81
7.3 Company Profiles 82
3M Health Care Limited 82
Adherium Limited 84
Amiko Digital Health Limited 85
AsthmaMD 86
AstraZeneca plc 87
Boehringer Ingelheim International GmbH 88
Capsule Technologies, Inc. 89
Cohero Health 90
GlaxoSmithKline plc 91
Kaia Health Software GmbH 92
Medical International Research (MIR) 93
Novartis AG 94
NuvoAir 95
Reciprocal Labs (Propeller Health) 96
Sensiron AG 97
Tactio Health 98
Teva Pharmaceuticals Industries Ltd. 99
8 Investing in Europe Market: Risk Assessment and Management 100
8.1 Risk Evaluation of Europe Market 100
8.2 Critical Success Factors (CSFs) 103
Related Reports and Products 106
Table 1. Snapshot of Europe Digital Respiratory Solutions Market, 2019-2030 17
Table 2. Main Product Trends and Market Opportunities in Europe Digital Respiratory Solutions Market 29
Table 3. Europe Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 38
Table 4. Europe Digital Respiratory Solutions Market: Therapeutic Devices by Type, 2019-2030, $ mn 40
Table 5. Europe Digital Respiratory Solutions Market: Diagnostic Devices by Type, 2019-2030, $ mn 44
Table 6. Europe Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 49
Table 7. Europe Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 55
Table 8. Europe Digital Respiratory Solutions Market by Country, 2019-2030, $ mn 62
Table 9. Germany Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 64
Table 10. Germany Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 64
Table 11. Germany Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 64
Table 12. UK Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 67
Table 13. UK Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 67
Table 14. UK Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 67
Table 15. France Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 69
Table 16. France Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 69
Table 17. France Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 69
Table 18. Spain Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 71
Table 19. Spain Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 71
Table 20. Spain Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 71
Table 21. Italy Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 73
Table 22. Italy Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 73
Table 23. Italy Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 73
Table 24. Russia Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 75
Table 25. Russia Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 75
Table 26. Russia Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 75
Table 27. Digital Respiratory Solutions Market in Rest of Europe by Country, 2019-2030, $ mn 77
Table 28. 3M Health Care Limited: Company Snapshot 82
Table 29. 3M Health Care Limited: Business Segmentation 82
Table 30. 3M Health Care Limited: Product Portfolio 83
Table 31. 3M Health Care Limited: Revenue, 2016-2018, $ mn 83
Table 32. 3M Health Care Limited: Recent Developments 83
Table 33. Risk Evaluation for Investing in Europe Market, 2019-2030 101
Table 34. Critical Success Factors and Key Takeaways 104
